Literature DB >> 15051146

Behavioral and electrophysiological evidence for tolerance to continuous morphine administration into the ventrolateral periaqueductal gray.

D A Lane1, V Tortorici, M M Morgan.   

Abstract

Repeated microinjections of morphine into the ventrolateral periaqueductal gray (vPAG) produce tolerance to the antinociceptive effect of morphine [Behav Neurosci 113 (1999) 833]. These results may be a direct effect of morphine on cells within the vPAG or be caused by cues linked to the microinjection procedure (i.e. associative tolerance). The objective of this paper was to determine whether continuous administration of morphine into the vPAG (i.e. no cues) would produce tolerance. Tolerance was assessed by measuring changes in behavior and changes in the activity of neurons in the rostral ventromedial medulla (RVM), the primary output target of the PAG. Rats were implanted with an osmotic minipump that released morphine (2.5 or 5 microg/h) or saline into the vPAG continuously. Continuous administration of morphine produced an increase in hotplate latency when measured 6 h after initiation of treatment. Tolerance to this antinociception was evident within 24 h. After 3 days, rats were anesthetized and the activity of RVM neurons was assessed. Although acute morphine administration into the RVM inhibits the activity of RVM on-cells and enhances the activity of off-cells, these neurons appeared normal following 3 days of continuous morphine administration. Systemic naloxone administration produced hyperalgesia that was associated with a marked increase in on-cell activity and a complete cessation of off-cell activity. The loss of morphine inhibition of nociception, measured behaviorally and electrophysiologically, demonstrates that tolerance is caused by a direct action of morphine on vPAG neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051146     DOI: 10.1016/j.neuroscience.2004.01.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  Chronic morphine exposure increases the proportion of on-cells in the rostral ventromedial medulla in rats.

Authors:  Ian D Meng; Ichiro Harasawa
Journal:  Life Sci       Date:  2007-02-24       Impact factor: 5.037

Review 2.  Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  Peptides       Date:  2019-03-16       Impact factor: 3.750

3.  Periaqueductal gray neuroplasticity following chronic morphine varies with age: role of oxidative stress.

Authors:  D Bajic; C B Berde; K G Commons
Journal:  Neuroscience       Date:  2012-09-19       Impact factor: 3.590

4.  Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat.

Authors:  Kyle N Campion; Kimber A Saville; Michael M Morgan
Journal:  Eur J Neurosci       Date:  2016-09-14       Impact factor: 3.386

5.  Sexually dimorphic activation of the periaqueductal gray-rostral ventromedial medullary circuit during the development of tolerance to morphine in the rat.

Authors:  Dayna R Loyd; Michael M Morgan; Anne Z Murphy
Journal:  Eur J Neurosci       Date:  2008-03       Impact factor: 3.386

6.  Periaqueductal Gray and Rostromedial Tegmental Inhibitory Afferents to VTA Have Distinct Synaptic Plasticity and Opiate Sensitivity.

Authors:  Robyn St Laurent; Valentina Martinez Damonte; Ayumi C Tsuda; Julie A Kauer
Journal:  Neuron       Date:  2020-03-18       Impact factor: 17.173

7.  Supraspinal Gbetagamma-dependent stimulation of PLCbeta originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia.

Authors:  Enrica Bianchi; Monica Norcini; Alan Smrcka; Carla Ghelardini
Journal:  J Neurochem       Date:  2009-07-27       Impact factor: 5.372

8.  Persistent peripheral inflammation attenuates morphine-induced periaqueductal gray glial cell activation and analgesic tolerance in the male rat.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  J Pain       Date:  2013-02-05       Impact factor: 5.820

9.  Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat.

Authors:  Melissa L Mehalick; Susan L Ingram; Sue A Aicher; Michael M Morgan
Journal:  J Pain       Date:  2013-10-22       Impact factor: 5.820

10.  Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.

Authors:  Adrianne R Wilson; Lauren Maher; Michael M Morgan
Journal:  Neuropharmacology       Date:  2008-08-05       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.